Á¦31ȸ ´ëÇѱâÃÊÀÇÇÐ Çмú´ëȸ (2ÀÏÂ÷) - ¿Â/¿ÀÇÁ º´Çà : 2024-06-28
±³À°ÀÏÀÚ : 2024-06-28
±³À°Àå¼Ò : °æÈñ´ëÇб³ ¼¿ïÄ·ÆÛ½º ½ºÆäÀ̽º21
±³À°ÁÖÁ¦ : Á¦31ȸ ´ëÇѱâÃÊÀÇÇÐ Çмú´ëȸ (2ÀÏÂ÷) - ¿Â/¿ÀÇÁ º´Çà
ÁÖÃÖ±â°ü : ´ëÇѱâÃÊÀÇÇÐÇùÀÇȸ
´ã´çÀÚ : »ç¹«±¹
¿¬¶ôó : 053-766-0006
À̸ÞÀÏ : kbms@gbc.or.kr
±³À°Á¾·ù : ÀÇ»çÇÐ, ¹ýÀÇÇÐ, ÇغÎÇÐ, ¾à¸®ÇÐ
Âü¼®¿¹»óÀÎ : 1000¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 20 ½Ã°£ 25ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í »çÀüµî·Ïºñ ÀϹÝ(±³¼ö, ¿¬±¸±³¼ö, ¼±ÀÓ¿¬±¸¿ø, ÀÇ»ç, ¿¬±¸±â°ü °ø¹«¿ø) 100,000¿ø / ´ëÇпø»ý, Àü°øÀÇ, ±ºÀÇ°ü, ¿¬±¸¿ø, °£È£»ç, ±âŸ 50,000¿ø / ¸í¿¹±³¼ö, ÀÇ°ú´ëÇлý, Çкλý ¹«·á ÇöÀåµî·Ïºñ ÀÏ¹Ý 120,000¿ø / ´ëÇпø»ý ¿Ü 70,000¿ø / ÀÇ°ú´ëÇлý ¿Ü ¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06¿ù 28ÀÏ B101È£/102È£ 10:00~10:30 Alveolar Organoid and gene edition for pulmonary fibrosis and drug testing È«¼®È£(°¿øÀÇ´ë)
±³À°½Ã°£ 06¿ù 28ÀÏ B101È£/102È£ 10:30~11:00 Metabolic disease and CNS disease ¼ÛÁÖÇö(Àü³²ÀÇ´ë)
±³À°½Ã°£ 06¿ù 28ÀÏ B101È£/102È£ 11:00~11:30 In vitro nonclinical trials in Osong Korea MPS center ÃÖÄ¡ÈÆ(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 06¿ù 28ÀÏ B101È£/102È£ 11:30~12:00 Is Parkinson¡¯s disease an autoimmune disease?: The role of adaptive immunity on Parkinson¡¯s disease pathogenesis À±½ÂÇÊ(°æ»óÀÇ´ë)
ÈÞ½Ä 06¿ù 28ÀÏ B101È£/102È£ 12:00~13:00 Á¡½É½Ä»ç ()
±âŸ 06¿ù 28ÀÏ B101È£/102È£ 13:00~14:00 Poster Session ±è¿ëÁØ(°æÈñÀÇ´ë)
±âŸ 06¿ù 28ÀÏ B101È£/102È£ 14:00~15:00 ÀÇ°úÇÐÀÚÀÇ Ä£±¸ Gustav Klimt°¡ ±×¸° ÀÇÇаú ¿¹¼úÀÇ ¸¸³² À¯ÀÓÁÖ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06¿ù 28ÀÏ B101È£/102È£ 15:00~15:25 Wireless neural interface systems for the investigation of functional neural circuits Á¶ÀÏÁÖ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06¿ù 28ÀÏ B101È£/102È£ 15:25~15:50 Holotomography and artificial intelligence: label-free 3D imaging, classification, and inference of live cells, tissues, and organoids ¹Ú¿ë±Ù(KAIST)
±³À°½Ã°£ 06¿ù 28ÀÏ B101È£/102È£ 15:50~16:10 Advanced human iPSC-based OASIS model for Parkinson ±è¹Î¼º(¼¼Á¾´ë)
±³À°½Ã°£ 06¿ù 28ÀÏ B101È£/102È£ 16:10~16:30 Development of small-molecule based immunomodulators ÀÌ»óÈñ(KAIST)
±³À°½Ã°£ 06¿ù 28ÀÏ B101È£/102È£ 16:30~16:50 Next-generation programmed photodynamic cancer therapy ±èµµ°æ(°æÈñ´ë)
Åä·Ð 06¿ù 28ÀÏ B101È£/102È£ 16:50~17:00 Q&A ()
±âŸ 06¿ù 28ÀÏ B101È£/102È£ 17:00~17:30 ¹ÙÀÌ¿À/ÀÇ¾à ±â¼úÀÇ ±â¼ú»ç¾÷È Àü·« ½Å¿ë¿î(º¯¸®»ç À§ ƯÇã¹ýÀÎ)
±âŸ 06¿ù 28ÀÏ B101È£/102È£ 17:30~18:00 ¹ÙÀÌ¿ÀÅØ ±â¼ú»ç¾÷È Àü·« A to Z ¹®ÃÊÇý(Æнº¿þÀÌ ÆÄÆ®³Ê½º)
±âŸ 06¿ù 28ÀÏ B101È£/102È£ 18:00~19:00 Æóȸ½Ä ±èµµ°æ(°æÈñÀÇ´ë)
±³À°½Ã°£ 06¿ù 28ÀÏ 263È£/264È£ 10:20~11:10 ±¹Á¦Ç¥Áرâ¹Ý ÀÓ»óµ¥ÀÌÅÍ Ç¥ÁØÈ ¹× ´Ù±â°ü °øµ¿¿¬±¸ ¹Ú·¡¿õ(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 06¿ù 28ÀÏ 263È£/264È£ 11:10~12:00 Data-Driven AI: Transforming Future Medicine Á¶¼öÀÍ(·ç´Ö)
ÈÞ½Ä 06¿ù 28ÀÏ 263È£/264È£ 12:00~13:00 Á¡½É½Ä»ç ()
±³À°½Ã°£ 06¿ù 28ÀÏ 263È£/264È£ 13:00~13:40 DNA methylationÀÇ ¹ýÀÇÇÐÀû È°¿ë ÀÌȯ¿µ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06¿ù 28ÀÏ 263È£/264È£ 13:40~14:10 Àΰ£ Àü»çü µ¥ÀÌÅͺ£À̽º¸¦ ÀÌ¿ëÇÑ ÀÏÁֱ⠻ýü½Ã°è ±â´É ¿¬±¸: ÀÏÁֱ⼺ À¯ÀüÀÚ ¹ßÇö Áöµµ¿Í ¹ýÀÇÇÐÀû È°¿ë Àü·« ¼Õ±âÈÆ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06¿ù 28ÀÏ 263È£/264È£ 14:10~14:35 ºòµ¥ÀÌÅÍ ¹× AI¸¦ È°¿ëÇÑ ¹ýÀÇÇבּ¸ÀÇ Ãֽŵ¿Çâ ÀÌÁ¤Çý(±¹°ú¼ö)
ÈÞ½Ä 06¿ù 28ÀÏ 263È£/264È£ 14:35~14:55 Break Time ()
±³À°½Ã°£ 06¿ù 28ÀÏ 263È£/264È£ 14:55~15:35 ¹ýÀÇÀηùÇп¡¼ÀÇ ÀÎü3Â÷¿ø ¿µ»ó ºòµ¥ÀÌÅÍ ¿¬±¸ÀÇ ÇöÀç ÀÌ¿øÁØ(±¹°ú¼ö)
±³À°½Ã°£ 06¿ù 28ÀÏ 263È£/264È£ 15:35~16:00 ¹ýÄ¡ÀÇÇÐ AI Àû¿ë¿¡ ´ëÇÑ ¿¬±¸ ³ëº´À±(±¹°ú¼ö)
ÈÞ½Ä 06¿ù 28ÀÏ 263È£/264È£ 16:00~16:10 Break Time ()
±³À°½Ã°£ 06¿ù 28ÀÏ 263È£/264È£ 16:10~16:25 The significance of diatom analysis in the field of sphenoid sinus and duodenum for the diagnosis of drowning °í¿µ»ê(±¹°ú¼ö)
±³À°½Ã°£ 06¿ù 28ÀÏ 263È£/264È£ 16:25~16:40 Postmortem diagnosis of blood-born infectious disease using point-of-care test kits ±è°¡Àº(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06¿ù 28ÀÏ 263È£/264È£ 16:40~16:55 Fatal Nitrites Poisoning in Medical Setting Filed as Alleged Medical Negligence or Malpractice; From the Perspective of the Role of Death Investigation ¹Ú¼ÒÇü(±¹°ú¼ö)
±³À°½Ã°£ 06¿ù 28ÀÏ 263È£/264È£ 16:55~17:10 Application of YOLO model for automated diatom detection: pilot study Àü¼öÁ¤(±¹°ú¼ö)
±âŸ 06¿ù 28ÀÏ 263È£/264È£ 17:10~17:20 ÃÑȸ ¹× Æóȸ»ç ()
±âŸ 06¿ù 28ÀÏ B110È£ 14:00~14:15 ±¸¿¬¹ßÇ¥ 1 ()
±âŸ 06¿ù 28ÀÏ B110È£ 14:15~14:30 ±¸¿¬¹ßÇ¥ 2 ()
±³À°½Ã°£ 06¿ù 28ÀÏ B110È£ 14:30~14:55 Searching the molecular space for drug discovery using deep neural networks ¼®Â÷¿Á(¼¿ï´ë(ÈÇкÎ))
±³À°½Ã°£ 06¿ù 28ÀÏ B110È£ 14:55~15:20 Saturation resistance profiling of EGFR variants against tyrosine kinase inhibitors using prime editing ±èÇü¹ü(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06¿ù 28ÀÏ B110È£ 15:20~15:45 De novo design of antibody by AI based on large-scale antibody-antigen binding data À±Å¿µ(¼¿ï´ë(»ý¸í°úÇкÎ))
ÈÞ½Ä 06¿ù 28ÀÏ B110È£ 15:45~16:05 Break Time ()
±³À°½Ã°£ 06¿ù 28ÀÏ B110È£ 16:05~16:30 Framework for individualized oligonucleotide therapy ±èÁø±¹(KAIST(ÀÇ°ú´ëÇпø))
±³À°½Ã°£ 06¿ù 28ÀÏ B110È£ 16:30~16:55 Electronic neural interfaces using liquid metals ¹ÚÀå¿õ(¿¬¼¼´ë(½Å¼Ò»õ°øÇкÎ))
±³À°½Ã°£ 06¿ù 28ÀÏ B110È£ 16:55~17:20 Early detection of cancer using circulating tumor DNA liquid biopsy ±èÅÂÀ¯(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06¿ù 28ÀÏ B110È£ 17:20~17:45 Pick your cell: Unveiling the untapped potential of SLACS in pharmacology ±Ç¼ºÈÆ(¼¿ï´ë(Àü±âÁ¤º¸°øÇкÎ))
±âŸ 06¿ù 28ÀÏ B126È£ 09:30~09:40 °³È¸»ç ¹ÚÀ±Àç(´ëÇÑÀÇ»çÇÐȸ ȸÀå)
±³À°½Ã°£ 06¿ù 28ÀÏ B126È£ 09:40~09:55 ¹ßÇ¥ 1: ÀÇ·áÀι®ÇÐ ±³À°ÀÇ °æ°ú ¹× ºñÆÇ ±Çº¹±Ô(ÀÌÈ¿©´ë)
±³À°½Ã°£ 06¿ù 28ÀÏ B126È£ 09:55~10:10 ¹ßÇ¥ 2: ÀÇ·áÀι®ÇÐ ±³À°ÀÇ ÀÇÀÇ À¯»óÈ£(ÇѾç´ë)
±âŸ 06¿ù 28ÀÏ B126È£ 10:10~10:25 ±âº»ÀÇÇб³À°¿¡¼ ÇÐȸº° ±³À° ÇöȲ ¹× ¸ñÇ¥ - ´ëÇÑÀÇ»çÇÐȸ ±èÅÃÁß(ÀÎÁ¦´ë)
±âŸ 06¿ù 28ÀÏ B126È£ 10:25~10:40 ±âº»ÀÇÇб³À°¿¡¼ ÇÐȸº° ±³À° ÇöȲ ¹× ¸ñÇ¥ - Çѱ¹ÀÇöÇÐȸ ȲÀÓ°æ(Á¦ÁÖ´ë)
±âŸ 06¿ù 28ÀÏ B126È£ 10:40~10:55 ±âº»ÀÇÇб³À°¿¡¼ ÇÐȸº° ±³À° ÇöȲ ¹× ¸ñÇ¥ - ´ëÇÑÀÇ·áÄ¿¹Â´ÏÄÉÀ̼ÇÇÐȸ ÃÖÀº°æ(°æºÏ´ë)
±âŸ 06¿ù 28ÀÏ B126È£ 10:55~11:10 ±âº»ÀÇÇб³À°¿¡¼ ÇÐȸº° ±³À° ÇöȲ ¹× ¸ñÇ¥ - Çѱ¹ÀÇ·áÀ±¸®ÇÐȸ ¹Ú¼Ò¿¬(°æÈñ´ë)
Åä·Ð 06¿ù 28ÀÏ B126È£ 11:10~12:00 ÁöÁ¤Åä·Ð Á¤À¯¼®, ¿¹º´ÀÏ, ¹®À翵, ¾È´ö¼±(´Ü±¹´ë, ´Ü±¹´ë, Ãæ³²´ë, °í·Á´ë)
ÈÞ½Ä 06¿ù 28ÀÏ B126È£ 12:00~13:30 Á¡½É½Ä»ç ¹× ÈÞ½Ä ()
±âŸ 06¿ù 28ÀÏ B126È£ 13:30~13:40 °³È¸»ç ¹ÚÀ±Àç(´ëÇÑÀÇ»çÇÐȸ ȸÀå)
±³À°½Ã°£ 06¿ù 28ÀÏ B126È£ 13:40~14:00 ÀÇ°ú´ëÇÐÀÇ ÀÇ»çÇÐ ±³À°: °¡Å縯´ëÀÇ °æÇè ¹Ú½Â¸¸(°¡Å縯´ë)
±³À°½Ã°£ 06¿ù 28ÀÏ B126È£ 14:00~14:20 ÀϹݱ³¾ç ±³°ú·Î¼ÀÇ ÀÇ»çÇаú ÅëÇÕ±³À°ÀÇ ÀÇÀÇ: ¡®Áúº´°ú Ä¡·á·Î º» ¼¾ç»ç¡¯¸¦ Áß½ÉÀ¸·Î ÀÌÇöÁÖ(´Ü±¹´ë)
±³À°½Ã°£ 06¿ù 28ÀÏ B126È£ 14:20~14:40 ´ëÁß ¼ÓÀÇ ÀÇ·áÀι®ÇÐ Á¶Å±¸(°æÈñ´ë(Áö¿ªÀι®Çм¾ÅÍ))
±âŸ 06¿ù 28ÀÏ B126È£ 14:40~15:00 ½Ã´ë¿Í ÇÔ²² º¯ÈÇÏ´Â ÀǾà¹Ú¹°°ü ±èÇý³ª(Çѵ¶ÀǾà¹Ú¹°°ü)
ÈÞ½Ä 06¿ù 28ÀÏ B126È£ 15:00~15:20 Break Time ()
±âŸ 06¿ù 28ÀÏ B126È£ 15:20~15:40 ·®Ä¡Â÷¿À(ÕÙÌöõ±)ÀÇ º´°ú Á×À½, ±×¸®°í ½Å³ä°ú Áø½Ç°ú ¿ª»ç Ȳ»óÀÍ(¼¿ï´ë)
±âŸ 06¿ù 28ÀÏ B126È£ 15:40~16:00 "¡®´ç½Å¡¯°ú ÇÔ²² ¸»Çϱâ: ÇѼ¾º´ Àü¹®ÀÇ»ç À¯ÁØ(׳ñç, Joon Lew) ¹Ú»çÀÇ ÀÚÀü Àû ±â¾ï¿¡¼ µè´Â °è¸ù»ç¾÷ ¼³°è" ÇѼø¹Ì(Á¶¼±´ë)
±³À°½Ã°£ 06¿ù 28ÀÏ B126È£ 16:00~16:20 °í´ë ·Î¸¶ÀÇ »êÆÄ¿¡ ´ëÇÑ ÀÎ½Ä ¹è¼Ò¿¬(¿ëÀδë)
±³À°½Ã°£ 06¿ù 28ÀÏ B126È£ 16:20~16:40 °áÇÔ°ú Áúº´ »çÀÌ¿¡¼: ·Î·±½º Äݺê(Lawrence C. Kolb)¿Í Áßµ¶ÀÇ °³³ä À̳²Èñ(ÀÌÈ¿©´ë(ÀÌÈ»çÇבּ¸¼Ò))
±³À°½Ã°£ 06¿ù 28ÀÏ B126È£ 16:40~17:00 ½ÄÇ°°ú °Ç°: 20¼¼±â ¹Ì±¹¿¡¼ÀÇ ½ÄÀÌÁöħÀ» Áß½ÉÀ¸·Î À̵¿±Ô(°æÈñ´ë)
±³À°½Ã°£ 06¿ù 28ÀÏ B126È£ 17:00~17:20 "Á¶°è ÇàÁ¤ ¼ÓÀÇ À§»ý ÇàÁ¤: 1899³â È®Àå ÀÌÈÄ »óÇØ °ø°øÁ¶°èÀÇ ºÐ´¢ ¹× ¾² ·¹±â ó¸® ¹®Á¦" ±è½Â·¡(°æÈñ´ë)
±³À°½Ã°£ 06¿ù 28ÀÏ B126È£ 17:20~17:40 "ÀÇ·á±ÕÁ¡°ú Çö´ëÈ »çÀÌ¿¡¼: 1970-80³â´ë Çѱ¹ Á¤ºÎÀÇ ÀÏÂ÷º¸°ÇÀÇ·á È®Ãæ Á¤Ã¥ÀÇ ¼º°Ý°ú ±× ¿ª»çÀû ÀǹÌ" Á¤´ÙÇý(°í·Á´ë(¿©¼ºÀÇÇл翬±¸¼Ò))
±âŸ 06¿ù 28ÀÏ B126È£ 17:40~18:00 ÃÑȸ ()
±âŸ 06¿ù 28ÀÏ B126È£ 18:00~18:00 Æóȸ ()
±³À°½Ã°£ 06¿ù 28ÀÏ B129È£ 09:00~09:50 ÀÇ·á±â±â R&D ¾î¶»°Ô ÇÒ±î? : ÀÓ»óÇöÀå¿¡¼ ÀÓ»óÇö»ó±îÁö ±è¹ý¹Î(¹üºÎóÀÇ·á±â±â»ç¾÷´Ü)
ÈÞ½Ä 06¿ù 28ÀÏ B129È£ 09:50~10:00 Break Time ()
±³À°½Ã°£ 06¿ù 28ÀÏ B129È£ 10:00~10:50 È£Èí±â´É ÃøÁ¤°ú ÂüÁ¶Ç¥ÁØ °³¹ß ¹ýÈ¿Áø(¿¬¼¼´ë(¸¶ÃëÅëÁõÀÇÇаú))
ÈÞ½Ä 06¿ù 28ÀÏ B129È£ 10:50~11:00 Break Time ()
±³À°½Ã°£ 06¿ù 28ÀÏ B129È£ 11:00~11:50 ÃøÁ¤Àº ±â°è°¡ ¾Æ´Ñ »ç¶÷ÀÌ ÇÑ´Ù ÃÖÁ¾¿À(¼é·Î¼ºÇâ»ó¿¬±¸¼Ò)
±âŸ 06¿ù 28ÀÏ B110È£ 10:00~10:20 ±¸¿¬¹ßÇ¥ ()
±³À°½Ã°£ 06¿ù 28ÀÏ B110È£ 10:20~10:40 Anatomy of Intervention: Leveraging Gross Anatomy for Clinical Applications ¹Ú±¤¶ô(»óÁö´ë(ÇÑÀÇ°ú´ëÇÐ))
±³À°½Ã°£ 06¿ù 28ÀÏ B110È£ 10:40~11:00 Revealing aberrant developmental mechanisms in brain cancer at a single-cell resolution ±èÇöÁ¤(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06¿ù 28ÀÏ B110È£ 11:00~11:20 Changes in structural plasticity of hippocampal neurons in an animal model of multiple sclerosis °¼ÒÈñ(°æ»óÀÇ´ë)
±³À°½Ã°£ 06¿ù 28ÀÏ B110È£ 11:20~11:40 Epigenetic Regulation of Autophagy ±èµ¿ÇÏ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06¿ù 28ÀÏ B110È£ 11:40~12:00 Role of STAMP2 in metabolic dysfunction-associated fatty liver disease ±èÇý¿µ(ÀÎÁ¦ÀÇ´ë)